.FDA denies psychedelic MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Decreases to Accept MDMA Treatment, Finding Even More Study The New York TimesFDA Declines Ecstasy-Based Medicine The Stock market JournalFDA declines to authorize novel MDMA therapy to address post-traumatic stress disorder, along with ask for even more litigation data CNNFDA turns down initially experimental to address post-traumatic stress disorder, calling for additional research The Washington Message.